Niche Glyco Analysis IonDX has developed a glycosylation analysis pipeline for biotherapeutics using novel ion mobility spectrometry, presenting a potential sales angle to pharma and biotech clients seeking faster, reliable glycan profiling in high-throughput workflows.

High Throughput Innovation The company emphasizes high throughput analysis of proteins and biotherapeutics, offering opportunities to engage large biopharma and contract research organizations aiming to scale analytical capabilities and reduce time-to-insight.

Senior Expertise Founders bring over four decades of experience in analytical instrumentation for biomacromolecules and nanomaterials, enabling credible outreach to R&D leadership and decision makers valuing deep technical credibility and mentorship potential.

Early Revenue Growth With current revenue in the low millions and recent modest funding, IonDX presents a door for strategic partnerships, pilot programs, and grant-funded collaborations to expand product validation and customer adoption.

Strategic Collaborations Past collaboration with GlycoSelect on glycosylation pipelines indicates a readiness for co-development opportunities; target biotech firms and CROs pursuing glycomics, structural biology, and analytical instrumentation enhancements.